These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16231261

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Salivary gland disease in pediatric HIV patients: an update.
    Pinto A, De Rossi SS.
    J Dent Child (Chic); 2004; 71(1):33-7. PubMed ID: 15272653
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?
    Kaufman DA.
    Curr Opin Pediatr; 2008 Jun; 20(3):332-40. PubMed ID: 18475105
    [Abstract] [Full Text] [Related]

  • 66. Candidiasis (oropharyngeal).
    Pankhurst C.
    Clin Evid; 2005 Jun; (13):1701-16. PubMed ID: 16135307
    [No Abstract] [Full Text] [Related]

  • 67. Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence.
    Dutta S, Murki S, Varma S, Narang A, Chakrabarti A.
    Indian Pediatr; 2005 Dec; 42(12):1226-30. PubMed ID: 16424560
    [Abstract] [Full Text] [Related]

  • 68. Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals.
    Mane A, Panchvalli S, Bembalkar S, Risbud A.
    Indian J Med Res; 2010 Jun; 131():836-8. PubMed ID: 20571177
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
    Blot SI, Hoste EA, Vandewoude KH, Colardyn FA.
    Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521
    [No Abstract] [Full Text] [Related]

  • 71. Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient.
    Bodasing N, Seaton RA, Shankland GS, Pithie A.
    J Antimicrob Chemother; 2002 Nov; 50(5):765-6. PubMed ID: 12407143
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL, Lo HJ, Hung CC, Li Y.
    BMC Infect Dis; 2006 Jan 20; 6():8. PubMed ID: 16423306
    [Abstract] [Full Text] [Related]

  • 77. [Desensitization to fluconazole in patient with human inmunodeficiency virus infection].
    Del Arco A, Prada JL, de La Torre J, Romualdo L.
    Med Clin (Barc); 2002 Jun 15; 119(2):77. PubMed ID: 12084379
    [No Abstract] [Full Text] [Related]

  • 78. Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
    Dupont B, Drouhet E.
    Ann N Y Acad Sci; 1988 Jun 15; 544():564-70. PubMed ID: 2850757
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.